Main Management ETF Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.01M Buy
112,128
+1,824
+2% +$16.3K 0.04% 88
2025
Q1
$827K Buy
+110,304
New +$827K 0.04% 88